Stage IB Pancreatic Cancer Suspended Phase 1 Trials for Capecitabine (DB01101)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0034490 (Stage IB Pancreatic Cancer) | Suspended | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01918644 | Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer | Treatment |